These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 551974)

  • 1. An evaluation of the leading patent equivalents services.
    Johns TM; Andrus WG; De Voe S; Myers J; Smith RG; Uhlir O
    J Chem Inf Comput Sci; 1979 Nov; 19(4):241-6. PubMed ID: 551974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 3. Could patents interfere with the development of a cardiovascular polypill?
    Beall RF; Schwalm JD; Huffman MD; McCready T; Yusuf S; Attaran A
    J Transl Med; 2016 Aug; 14(1):242. PubMed ID: 27538505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supreme Court rules against drug patent "evergreening".
    Kondro W
    CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using bibliometric analyses of patent literature for predicting the clinical fates of developing drugs.
    Windsor DA
    J Chem Inf Comput Sci; 1979 Nov; 19(4):218-21. PubMed ID: 399483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent quality.
    Sklan A
    Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extraterritoriality of US patents on the pharmaceutical industry.
    Park H
    Pharm Pat Anal; 2014 Sep; 3(5):491-8. PubMed ID: 25374318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revitalizing the patent system to incentivize pharmaceutical innovation: the potential of claims with means-plus-function clauses.
    Tang WL
    Duke Law J; 2013 Feb; 62(5):1069-108. PubMed ID: 25330553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical patents and price controls.
    Vogel RJ
    Clin Ther; 2002 Jul; 24(7):1204-22; discussion 1202-3. PubMed ID: 12182263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent coverage by abstracting services. 4. Coverage of microbiological patents.
    Oppenheim C; van den Ende J
    J Chem Inf Comput Sci; 1981 Aug; 21(3):124-7. PubMed ID: 7287832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of pharmaceutical patent litigation in China.
    Carver T
    Pharm Pat Anal; 2016; 5(2):75-7. PubMed ID: 26891143
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent law for the dermatologist.
    Mei DF; Liu J
    Semin Cutan Med Surg; 2013 Dec; 32(4):242-6. PubMed ID: 24800434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canada's Supreme Court abolishes 'promise of the patent'.
    Norman J; Gloor A
    Pharm Pat Anal; 2018 Jan; 7(1):1-5. PubMed ID: 29227204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent immorality?
    Bloche MG; Jungman ER
    Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
    [No Abstract]   [Full Text] [Related]  

  • 18. [An analysis of the decision of the Italian Constitutional Court repealing the ban on patents in the pharmaceutical field and of the subsequent provisions].
    Klausner E
    Farmaco Prat; 1980 Aug; 35(8):381-90. PubMed ID: 7449957
    [No Abstract]   [Full Text] [Related]  

  • 19. Panel rules against Canada on patent terms for pre-TRIPS patents.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indian pharmaceutical patent prosecution: The changing role of Section 3(d).
    Sampat BN; Shadlen KC
    PLoS One; 2018; 13(4):e0194714. PubMed ID: 29608604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.